MEM · ASX

Memphasys Ltd (ASX:MEM)

AU$0.005

 -0.001 (-16.667%)
ASX:Live
20/12/2024 04:10:10 PM
HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MEM Overview

MEM Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

MEM Price Chart

Key Stats

Market Cap

AU$13.01M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

20%

1 month

9.09%

YTD

-53.85%

1 year

-45.45%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

MEM Announcements

Latest Announcements

Date Announcements

20 December 24

Bovine Study commences to assess RoXsta antioxidant system

×

Bovine Study commences to assess RoXsta antioxidant system

18 December 24

Felix Clinical Registration Study completed, expanding mkt

×

Felix Clinical Registration Study completed, expanding mkt

12 December 24

Letter of Intent with Heranova for Felix System Distribution

×

Letter of Intent with Heranova for Felix System Distribution

05 December 24

RoXsta System's Potential in Cattle Breeding being Explored

×

RoXsta System's Potential in Cattle Breeding being Explored

05 December 24

Order for Felix System to Evaluate Suitability in UAE

×

Order for Felix System to Evaluate Suitability in UAE

05 December 24

Notification of cessation of securities - MEM

×

Notification of cessation of securities - MEM

29 November 24

Second Supplementary Prospectus

×

Second Supplementary Prospectus

28 November 24

Extension of convertible note

×

Extension of convertible note

27 November 24

Initial Director's Interest Notice - LE

×

Initial Director's Interest Notice - LE

27 November 24

Final Director's Interest Notice - RC

×

Final Director's Interest Notice - RC

22 November 24

Address to Shareholders

×

Address to Shareholders

22 November 24

Results of Meeting

×

Results of Meeting

21 November 24

Chair Appointment/Resignation

×

Chair Appointment/Resignation

18 November 24

Felix Clinical Trial Reaches 95% Completion

×

Felix Clinical Trial Reaches 95% Completion

15 November 24

RoXsta System Secures Provisional Patent Approval

×

RoXsta System Secures Provisional Patent Approval

08 November 24

Application for quotation of securities - MEM

×

Application for quotation of securities - MEM

08 November 24

Notification regarding unquoted securities - MEM

×

Notification regarding unquoted securities - MEM

05 November 24

Completion of Placement and SPP offer

×

Completion of Placement and SPP offer

05 November 24

Application for quotation of securities - MEM

×

Application for quotation of securities - MEM

05 November 24

Notification regarding unquoted securities - MEM

×

Notification regarding unquoted securities - MEM

31 October 24

Alteration to Notice of Meeting (AGM venue)

×

Alteration to Notice of Meeting (AGM venue)

30 October 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

25 October 24

MEM Investor Presentation

×

MEM Investor Presentation

25 October 24

Results of Meeting

×

Results of Meeting

24 October 24

Felix Trial registration update

×

Felix Trial registration update

MEM Fundamentals

Per Share Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -33.3 25.0 -5.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock 0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -76.0 -13.5 -7.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.0 -5.5 -20.0 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.01 0.01 0.00 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -717.3 -23.9 19.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 858 1,922 2,310 Lock Lock Lock
Basic m Lock Lock Lock Lock 858 1,922 2,310 Lock Lock Lock

Financial Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -43.4 290.3 Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 2 3 4 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock -1 -1 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -255.5 10.6 -90.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,398.4 -5,366.3 -2,613.7 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 3,498 5,466 2,714 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -3 -3 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -80.2 -16.9 -49.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -9,517.2 -19,653.8 -7,536.0 Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -3 -4 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -59.8 -34.2 -44.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -9,971.0 -23,640.8 -8,731.2 Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -2 -3 -4 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -2 -3 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -40.1 -63.4 -30.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -7,668.9 -22,136.6 -7,403.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock 0 -1 -3 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 3 2 1 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock -3 -2 -1 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 1 4 4 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock 0 -1 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 536.2 -557.3 -128.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 11.4 -91.9 -53.9 Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 14 15 12 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 2 2 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock 5 6 5 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 6 7 6 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 8 7 7 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 10 9 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -30.3 -4.7 -21.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -14.7 -23.2 -35.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -27.2 -46.1 -65.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -19.9 -27.0 -41.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -17.9 -36.5 -54.6 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 2.7 -15.1 -39.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -4.5 -7.1 -10.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -2.0 -1.9 -1.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 68.7 77.1 66.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.4 0.4 0.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.4 0.4 0.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 15.4 30.3 17.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 6.9 -25.3 -61.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 9.2 7.7 11.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 485.0 751.0 656.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -7,668.9 -22,136.6 -7,403.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -14.7 -23.2 -35.7 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -14.7 -23.2 -35.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.8 2.0 1.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -27.2 -46.1 -65.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -27.2 -46.1 -65.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 39.6 47.3 33.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 19,255.8 33,481.9 7,403.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 19,295.4 33,529.2 7,436.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 57.7 51.0 55.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 19,237.7 33,478.2 7,380.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MEM Shortsell

Frequently Asked Questions

The current share price of Memphasys Ltd (MEM:ASX) is AU$0.005.
The 52-week high share price for Memphasys Ltd (MEM:ASX) is AU$0.00.
The 52-week low share price for Memphasys Ltd (MEM:ASX)? is AU$0.00.
Memphasys Ltd (MEM:ASX) does not pay a dividend.
Memphasys Ltd (MEM:ASX) does not pay a dividend.
Memphasys Ltd (MEM:ASX) does not offer franking credits.
Memphasys Ltd (MEM:ASX) is classified in the Healthcare.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.